Covered recipient · General Payments record
MATTIE KATHERINE ADAMS
Eye and Vision Services Providers Optometrist
General Payments · PY2021–2024
$3,054.52
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $793.17 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $177.31 | 4 |
| Genentech USA, Inc. | $173.10 | 2 |
| ABBVIE INC. | $167.76 | 7 |
| Apellis Pharmaceuticals, Inc. | $69.93 | 3 |
| Oyster Point Pharma, Inc. | $59.61 | 2 |
| Dompe US, Inc. | $49.68 | 2 |
| Tarsus Pharmaceuticals, Inc. | $24.11 | 1 |
| Astellas Pharma US Inc | $22.65 | 1 |
| Bausch & Lomb Americas Inc. | $20.24 | 1 |
| Harrow Eye, LLC | $15.60 | 1 |
| Alcon Laboratories Inc | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.82 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103174572 | CMS |
| ABBVIE INC. | $18.09 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103174574 | CMS |
| ABBVIE INC. | $23.27 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103174576 | CMS |
| ABBVIE INC. | $28.47 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103174578 | CMS |
| ABBVIE INC. | $23.61 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103174580 | CMS |
| ABBVIE INC. | $32.31 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103174582 | CMS |
| ABBVIE INC. | $27.19 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103174584 | CMS |
| Alcon Vision LLC | $13.18 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110696047 | CMS |
| Amgen Inc. | $19.35 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115409261 | CMS |
| Amgen Inc. | $124.74 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115409264 | CMS |
| Amgen Inc. | $15.44 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115409269 | CMS |
| Amgen Inc. | $17.78 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115409273 | CMS |
| Apellis Pharmaceuticals, Inc. | $22.34 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154025979 | CMS |
| Apellis Pharmaceuticals, Inc. | $18.64 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154025977 | CMS |
| Apellis Pharmaceuticals, Inc. | $28.95 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154025981 | CMS |
| Astellas Pharma US Inc | $22.65 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139428680 | CMS |
| Bausch & Lomb Americas Inc. | $20.24 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140407540 | CMS |
| Dompe US, Inc. | $22.92 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151411009 | CMS |
| Dompe US, Inc. | $26.76 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151411011 | CMS |
| Genentech USA, Inc. | $26.13 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133066813 | CMS |
| Genentech USA, Inc. | $146.97 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133066809 | CMS |
| Harrow Eye, LLC | $15.60 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145596456 | CMS |
| Oyster Point Pharma, Inc. | $30.04 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147429287 | CMS |
| Oyster Point Pharma, Inc. | $29.57 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147407684 | CMS |
| Tarsus Pharmaceuticals, Inc. | $24.11 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139078147 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.